Fibroblasts determine treatment outcome in rheumatoid arthritis

Puntos clave

• Treatment outcomes in rheumatoid arthritis can significantly vary, highlighting the role of fibroblasts.
• Key evidence shows that specific biomarkers related to fibroblasts influence responses to therapy in patients.
• Observational analysis determined the impact of fibroblasts on treatment outcomes in rheumatoid arthritis patients.
• These findings call for further investigation into fibroblast-related biomarkers to optimize treatment strategies.